Page 4 - Nasdaq Tech News Today

Bio-Techne (NASDAQ:TECH – Get Free Report) had its price objective dropped by investment analysts at Stifel Nicolaus from $104.00 to $65.00 in a research report issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. Stifel Nicolaus’ price target suggests a potential upside of 17.31% from the stock’s […]

Bio-Techne Co. (NASDAQ:TECH – Free Report) – Equities researchers at Leerink Partnrs lowered their Q3 2024 EPS estimates for Bio-Techne in a research note issued to investors on Tuesday, October 31st. Leerink Partnrs analyst P. Souda now forecasts that the biotechnology company will earn $0.40 per share for the quarter, down from their prior estimate […]

Bio-Techne Co. (NASDAQ:TECH – Free Report) – Investment analysts at KeyCorp increased their Q3 2024 EPS estimates for Bio-Techne in a research note issued to investors on Tuesday, October 31st. KeyCorp analyst P. Knight now expects that the biotechnology company will post earnings per share of $0.43 for the quarter, up from their previous estimate […]

StockNews.com upgraded shares of Bio-Techne (NASDAQ:TECH – Free Report) from a hold rating to a buy rating in a research note issued to investors on Friday. Several other equities analysts have also recently issued reports on the stock. TheStreet cut shares of Bio-Techne from a b- rating to a c+ rating in a research report […]

Rowland & Co. Investment Counsel ADV decreased its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.0% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 49,135 shares of the biotechnology company’s stock after selling 1,010 shares during the quarter. Rowland & Co. […]

Bio-Techne Co. (NASDAQ:TECH – Get Free Report)’s share price was down 6.9% during trading on Monday . The stock traded as low as $55.38 and last traded at $55.42. Approximately 278,978 shares traded hands during trading, a decline of 71% from the average daily volume of 962,305 shares. The stock had previously closed at $59.54. […]

Rowland & Co. Investment Counsel ADV lowered its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,135 shares of the biotechnology company’s stock after selling 1,010 shares during the […]

Bio-Techne Co. (NASDAQ:TECH – Get Free Report)’s share price fell 6.9% during trading on Monday . The company traded as low as $55.38 and last traded at $55.42. 278,978 shares were traded during trading, a decline of 71% from the average session volume of 962,305 shares. The stock had previously closed at $59.54. Analyst Ratings […]

Mackenzie Financial Corp boosted its position in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 14.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,129,001 shares of the biotechnology company’s stock after purchasing an additional 274,048 shares during the period. […]

Oppenheimer Asset Management Inc. lowered its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 1.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 62,657 shares of the biotechnology company’s stock after selling 1,018 shares during […]